Clinical Trials Browser

Phase 2 × Breast Neoplasms × arsenous acid × Clear all

NCT06678048 2025-06-06

Arsenous Acid for Refractory Triple-Negative Breast Cancer

Phase 2 Recruiting

Breast Neoplasms